Not applicableStudy completedNCT02071056
What this trial is testing
Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)
Who this might be right for
Leptomeningeal Metastasis
Dartmouth-Hitchcock Medical Center 5